Abstract
Schizophrenia and Parkinson ’s disease as Risk Factors for Melanoma Development and Progression!
Highlights
In 2016 the patient has been diagnosed with idiopathic aplastic anemia and since is on immunosuppressive therapy with Cyclosporine A 2x100mg/d
Since in schizophrenia the antidopaminergic therapy leads to clinical improvement and better quality of life, the positive effect in MM is still predominantly scientific and experimental [1]
Back in 1982 it was proved that the dopamine antagonists, used in treatment of schizophrenia, have inhibiting effect on melanoma cell lines [2]
Summary
In 2016 the patient has been diagnosed with idiopathic aplastic anemia and since is on immunosuppressive therapy with Cyclosporine A 2x100mg/d. The Positron Emission Tomography - Computed Tomography (PET/CT) suggested a generalized, oncologic disease with multiple metastasis in bones, lymph nodes and spleen, without skull involvement. Cutaneous melanoma and paranoid schizophrenia are two socially significant, multifactorial diseases, which share a common pathogenic mechanism [1].
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
